- Home
- FORTY vs IDYA Comparison
FORTY vs IDYA Comparison
Compare FORTY & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORTY
- IDYA
- Stock Information
- Founded
- FORTY 1985
- IDYA 2015
- Country
- FORTY Israel
- IDYA United States
- Employees
- FORTY N/A
- IDYA N/A
- Industry
- FORTY EDP Services
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- FORTY Technology
- IDYA Health Care
- Exchange
- FORTY Nasdaq
- IDYA Nasdaq
- Market Cap
- FORTY 2.3B
- IDYA 2.3B
- IPO Year
- FORTY 1997
- IDYA 2019
- Fundamental
- Price
- FORTY $140.00
- IDYA $31.86
- Analyst Decision
- FORTY
- IDYA Buy
- Analyst Count
- FORTY 0
- IDYA 17
- Target Price
- FORTY N/A
- IDYA $48.20
- AVG Volume (30 Days)
- FORTY 349.0
- IDYA 1.3M
- Earning Date
- FORTY 11-20-2025
- IDYA 11-04-2025
- Dividend Yield
- FORTY 0.95%
- IDYA N/A
- EPS Growth
- FORTY 15.06
- IDYA N/A
- EPS
- FORTY 4.97
- IDYA N/A
- Revenue
- FORTY $2,889,481,000.00
- IDYA $7,000,000.00
- Revenue This Year
- FORTY N/A
- IDYA $90.17
- Revenue Next Year
- FORTY N/A
- IDYA $219.42
- P/E Ratio
- FORTY $28.39
- IDYA N/A
- Revenue Growth
- FORTY 8.58
- IDYA N/A
- 52 Week Low
- FORTY $77.50
- IDYA $13.45
- 52 Week High
- FORTY $151.31
- IDYA $33.64
- Technical
- Relative Strength Index (RSI)
- FORTY 55.15
- IDYA 64.62
- Support Level
- FORTY $137.45
- IDYA $28.17
- Resistance Level
- FORTY $148.00
- IDYA $33.64
- Average True Range (ATR)
- FORTY 1.45
- IDYA 1.71
- MACD
- FORTY -0.49
- IDYA 0.28
- Stochastic Oscillator
- FORTY 43.68
- IDYA 75.28
About FORTY Formula Systems (1985) Ltd.
Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources, Michpal, ZAP Group, and Others. The majority of the company's revenue comes from Israel.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.